The global pandemic since early 2020 has provided great opportunities for healthcare service providers and companies. We have discussed these topics when the pandemic began. Now that some health care companies have grown their revenues and expanded the business, is it a good strategy for them to go initial public offerings in the post-pandemic era? Today, I will use the case of Moderna.INC to illustration this question.
